Buse, John B.

Comprehensive Pulmonary Safety Review of Inhaled Technosphere® Insulin in Patients with Diabetes Mellitus

McGill, J. B., Peters, A., Buse, J. B., Steiner, S., Tran, T., Pompilio, F. M., & Kendall, D. M. (2020) · Clinical Drug Investigation

Inhalation and Respiratory Drug DeliveryDiabetes Management and Research

Cited by 35

Liraglutide Reduces Cardiovascular Events and Mortality in Type 2 Diabetes Mellitus Independently of Baseline Low-Density Lipoprotein Cholesterol Levels and Statin Use: Results From the LEADER Trial

Verma, S., Leiter, L. A., Mazer, C. D., Bain, S. C., Buse, J., Marso, S., Nauck, M., Zinman, B., Bosch-Traberg, H., Rasmussen, S., et al. (2018) · Circulation

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 35

Is insulin the most effective injectable antihyperglycaemic therapy?

Buse, J. B., Peters, A., Russell‐Jones, D., Furber, S., Donsmark, M., Han, J., MacConell, L., Maggs, D., & Diamant, M. (2015) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 32

Carbohydrate Intake Prior to Oral Glucose Tolerance Testing

Klein, K. R., Walker, C. P., McFerren, A. L., Huffman, H., Frohlich, F., & Buse, J. B. (2021) · Journal of the Endocrine Society

Diabetes Management and ResearchPancreatic function and diabetes

Cited by 32

Bibliometrics approach to evaluating the research impact of CTSAs: A pilot study

Yu, F., Van, A. A., Patel, T., Mani, N., Carnegie, A., Corbie-Smith, G. M., Carey, T., Buse, J., & Dave, G. (2020) · Journal of Clinical and Translational Science

scientometrics and bibliometrics researchHealth and Medical Research Impacts

Cited by 26

Comparative safety of pioglitazone versus clinically meaningful treatment alternatives concerning the risk of bladder cancer in older US adults with type 2 diabetes

Garry, E. M., Buse, J. B., Lund, J. L., Pate, V., & Stürmer, T. (2018) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementMetabolism, Diabetes, and Cancer

Cited by 25

High-Dose Semaglutide (Up to 16 mg) in People With Type 2 Diabetes and Overweight or Obesity: A Randomized, Placebo-Controlled, Phase 2 Trial

Aroda, V. R., Jørgensen, N. B., Kumar, B., Lingvay, I., Laulund, A. S., Buse, J. B., & trial investigators (2025) · Diabetes Care

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 25

Recent Progress in Glucose-Responsive Insulin

Liu, Y., Wang, S., Wang, Z., Yu, J., Wang, J., Buse, J. B., & Gu, Z. (2024) · Diabetes

Diabetes Management and ResearchAdvanced Drug Delivery Systems

Cited by 19

The insulin-only bionic pancreas improves glycemic control in non-Hispanic White and minority adults and children with type 1 diabetes

Castellanos, L. E., Russell, S. J., Damiano, E. R., Beck, R. W., Shah, V. N., Bailey, R., Calhoun, P., Bird, K., Mauras, N., Bionic Pancreas Research Group, et al. (2023) · Diabetes Care

Diabetes Management and ResearchPancreatic function and diabetes

Cited by 11

Outcomes in patients with diabetes, atherosclerotic cardiovascular disease, and heart failure treated with tirzepatide or dulaglutide: SURPASS-CVOT analysis

Nicholls, S. J., Pavo, I., Bhatt, D. L., Buse, J. B., Del Prato, S., Franco, D. R., Kahn, S. E., Lincoff, A. M., Martins, R. F., McGuire, D. K., et al. (2026) · European Journal of Preventive Cardiology

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 0